| Literature DB >> 16377708 |
Yoshihiro Oyamada1, Hideaki Ito, Mika Fujimoto-Nakamura, Akihiko Tanitame, Noritaka Iwai, Kazuo Nagai, Jun-Ichi Yamagishi, Masaaki Wachi.
Abstract
About 95,000 compounds were screened by the anucleate cell blue assay. Fifty-one of the hit compounds had various structures and showed inhibitory activity against DNA gyrase and/or topoisomerase IV. Moreover, the compounds exhibited antibacterial activity against a fluoroquinolone- and novobiocin-resistant strain of Staphylococcus aureus. The anucleate cell blue assay is therefore a useful tool for finding novel type II topoisomerase inhibitors.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16377708 PMCID: PMC1346804 DOI: 10.1128/AAC.50.1.348-350.2006
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191